Aflac Cancer and Blood Disorders Center Receives $3.3 Million Gift from CURE Childhood Cancer

ATLANTA (August 13, 2025) - The Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta received a new $3.3 million gift commitment from CURE Childhood Cancer. Over the past five years, the organization has donated more than $12 million to the Aflac Cancer and Blood Disorders Center.

The majority of CURE's latest gift is allocated to the Precision Medicine Program at the Aflac Cancer and Blood Disorders Center, which was developed, in part, thanks to a previous gift from CURE in 2017. The Precision Medicine Program uses genetic testing methods to identify specific changes in the DNA and RNA of cancer cells, offering individualized treatment options to our pediatric cancer patients.

Additional funding from CURE has been awarded to the Kelly Goldsmith, MD, Muxiang Zhou, PhD and Manoj Bhasin, PhD for their research related to immunotherapies in pediatric solid tumors and treatment of acute myeloid leukemia.

"We are incredibly grateful to CURE for this generous gift and their continued support of the doctors, researchers and patient families within Children's," said Doug Graham, MD, PhD, Chief, Aflac Cancer and Blood Disorders Center. "Thanks to funding from CURE, our Precision Medicine Program has made significant strides over the past few years, and this additional funding will help identify new therapies and treatment options for our patient families in Georgia and around the country."

The latest gift also will fund the Hematology/Oncology Fellowship Program and provide critical financial assistance for families.